Baxter International Inc

Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to info@portnoylaw.com.

Are you a current or former employee of the company?*YesNo

Purchases

+Additional Purchases

Sales

+Additional Sales

If you prefer, you may submit your transaction information or comments/questions in the box below:




There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.

We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at info@portnoylaw.com.

If you choose to take no action, you can remain an absent class member.

Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.

The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

CONTACT:
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
www.portnoylaw.com
Office: 310.692.8883
1800 Century Park East, Suite 600
Los Angeles, CA 90067
info@portnoylaw.com

According to the complaint, the defendants are accused of making false and/or deceptive statements or failing to disclose the following: (i) The Company hid the true extent of its supply chain issues while exaggerating its ability to maintain a strong supply chain amidst global pressures; (ii) Consequently, the Company’s projected earnings were significantly misleading during the Class Period; (iii) Once these issues were revealed, they were expected to have a substantial negative impact on the Company’s financial condition; and (iv) As a result, the Company’s public statements were materially false and deceptive throughout the relevant period. As a consequence, Baxter’s stock price experienced a decline of approximately 50% during the Class Period, resulting in the loss of billions of dollars in market capitalization.